Pricing Log in Create free account

Sera Prognostics, Inc. (SERA) vs Zomedica Corp. (ZOMDF)

Sera Prognostics, Inc. and Zomedica Corp. are both Medical Devices companies. Zomedica Corp. is the larger, with a market value of $95.4M against $82.1M — 1.2× the size. Zomedica Corp. grew revenue faster over the last twelve months: 31.3% against 1.05%. Zomedica Corp. has the higher net margin (−41.4% vs −34,866.7%) and the higher return on invested capital (−17.1% vs −278.6%). Across the 16 metrics below, Zomedica Corp. leads on 15 and Sera Prognostics, Inc. on 1.

Valuation

Metric SERA ZOMDF Medical Devices median
P/E n/m n/m 25.58
P/S 1,100.45 2.28 2.54
P/B 2.01 0.85 2.48
Price to free cash flow n/m n/m 28.81
EV/EBITDA n/m n/m 11.51
EV/Sales 641.21 1.26 2.72
Earnings yield (32.21%) (18.00%) (12.82%)
Free cash flow yield (27.81%) (15.27%) (8.18%)

Profitability

Metric SERA ZOMDF Medical Devices median
Gross margin 0.00% 63.96% 57.76%
Operating margin (38,755.21%) (45.43%) (15.07%)
Net margin (34,866.67%) (41.35%) (14.45%)
Free cash flow margin (30,198.96%) (34.81%) (3.88%)
Return on equity (49.73%) (14.28%) (10.35%)
Return on assets (35.59%) (13.01%) (17.26%)
Return on invested capital (278.58%) (17.12%) (5.27%)

Growth

Metric SERA ZOMDF Medical Devices median
Revenue growth (TTM) 1.05% 31.33% 10.41%
EPS growth (last fiscal year) 32.32% (60.00%) 28.17%
Revenue growth, 5-year CAGR 26.51% — 15.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric SERA ZOMDF Medical Devices median
Debt to equity 0.00 0.00 0.04
Current ratio 1.88 6.09 2.74
Net debt to EBITDA 1.10 0.69 0.54

Dividend

Metric SERA ZOMDF Medical Devices median
Dividend yield — — 1.02%
Payout ratio — — 0.37

Size

Metric SERA ZOMDF Medical Devices median
Market cap 82.05m 95.35m 239.53m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack